In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction.

作者: B. Salomone , R. Ponti , M.R. Gasco , E. Ugazio , P. Quaglino

DOI: 10.1023/A:1013186331662

关键词:

摘要: Literature data show that butyric acid derivatives bear a dose-dependent differentiative anti-proliferative activity on cancer cell lines and apoptosis induction may play major role. Although it was recently shown solid lipid nanospheres (SLNs) are suitable tool for several in vivo drug administration routes, there is little available information melanoma lines. This study aimed at evaluating the apoptotic vitro effects of cholesteryl butyrate (chol-but) SLNs cells. Increasing concentrations chol-but were used to test two Both treated with Na-butyrate (Na-but) viability. Those tested more effective than Na-butirate (3 72 h). The evaluated between 3 72 h by annexin-V (ANX-V)/propidium iodide (PI) staining antiproliferative effect PI staining. Apoptosis anti-proliferative-regulatory proteins as bcl-2, Fas/APO1 (CD95) PCNA (PC10) also investigated. Flow cytometric analyses evidenced G0/1-S transition block `sub-G0/1' peak from 0.5 1.0 mM acid. In ANX-V/PI flow staining, dose- time-dependent increase percentage (ANX-V+) coupled down-regulation PC10 bcl-2 parallel up-regulation found both started after 24 h treatment. Results exerts dose/time-dependent dose but not

参考文章(65)
L. A. O'Reilly, D. C. Huang, A. Strasser, The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. The EMBO Journal. ,vol. 15, pp. 6979- 6990 ,(1996) , 10.1002/J.1460-2075.1996.TB01090.X
G Koopman, CP Reutelingsperger, GA Kuijten, RM Keehnen, ST Pals, MH van Oers, Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. ,vol. 84, pp. 1415- 1420 ,(1994) , 10.1182/BLOOD.V84.5.1415.1415
Lillian L. Siu, Daniel D. Von Hoff, Ada Rephaeli, Elzbieta Izbicka, Cesario Cerna, Lionel Gomez, Eric K. Rowinsky, S. Gail Eckhardt, Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units Investigational New Drugs. ,vol. 16, pp. 113- 119 ,(1998) , 10.1023/A:1006049227744
G Vidali, R S Mann, V G Allfrey, L C Boffa, Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. Journal of Biological Chemistry. ,vol. 253, pp. 3364- 3366 ,(1978) , 10.1016/S0021-9258(17)34804-4
Alessandro Bargoni, Roberta Cavalli, Otto Caputo, Anna Fundarò, Maria Rosa Gasco, Gian Paolo Zara, Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats Pharmaceutical Research. ,vol. 15, pp. 745- 750 ,(1998) , 10.1023/A:1011975120776
Catherine Kennedy, Christine L. Clarke, Anna deFazio, Yoke-Eng Chiew, Tracey Davis, Histone Deacetylase Inhibitors Decrease Proliferation and Modulate Cell Cycle Gene Expression in Normal Mammary Epithelial Cells Clinical Cancer Research. ,vol. 6, pp. 4334- 4342 ,(2000)
M VIALE, G MELIOLI, W PASQUETTI, M META, S CAFAGGI, N ESPOSITO, Modifications of cell-cycle induced by dpr, a new platinum-triamine complex containing procaine. International Journal of Oncology. ,vol. 4, pp. 1047- 1051 ,(1994) , 10.3892/IJO.4.5.1047
Manon van Engeland, Luc J.W. Nieland, Frans C.S. Ramaekers, Bert Schutte, Chris P.M. Reutelingsperger, Annexin V‐Affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure Cytometry. ,vol. 31, pp. 1- 9 ,(1998) , 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R